Study S003203

The Effect of Once-weekly Subcutaneous NNC0487-0111 Compared to an Energy-restricted Diet or Placebo on Energy Metabolism in Adults Living With Overweight or Obesity: a Randomised, Placebo-controlled Study

ClinicalTrials.gov record

Registration

Registration: NCT07757087
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 120
Start: 2026-08-03
Primary completion: 2028-09-18
Lead sponsor: Novo Nordisk A/S
Conditions: Overweight; Obesity
Interventions: DRUG:NNC0487-0111; DRUG:Placebo; BEHAVIORAL:LED
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1324-2934; OTHER:2025-522744-40; NIH:2025

Registered primary outcomes

Change in sleeping metabolic rate (SMR) [Baseline (week 0) to week 12-26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.